Lantheus Completes Acquisition of Evergreen Theragnostics [Yahoo! Finance]
Lantheus Completes Acquisition of Evergreen Theragnostics
Enigma Biomedical USA, Inc. Announces a Collaboration to Apply Novel 4R PET Imaging Biomarkers to CTE Research [Yahoo! Finance]
Lantheus Holdings: One Blockbuster, Evolving Pipeline [Seeking Alpha]
Lantheus Holdings, Inc. (NASDAQ: LNTH) had its price target lowered by analysts at B. Riley from $127.00 to $122.00. They now have a "buy" rating on the stock.